Saturday, January 19, 2019 3:06:13 PM
There were 30 patients in the BTD sub-group. Of these 40% 12/30 were confirmed responders (cORR). 5 of these 12 responders were censored (lost to evaluation for unknown reasons). 7 of the 12 responders were evaluated to provide the DOR of 6.6 months. Of the 7 evaluated responders 6 have a DOR over 6 months.
Of the evaluated confirmed responders 6 out of 7 have a DOR of over 6 months which is fantastic. However, the FDA wanted SPPI to provide evidence of cORR and 6 month+ DOR.
The 40% cORR was solid, BUT we believe that there were too few confirmed responders in the DOR analysis (just 7 patients) to satisfy the FDA.
Let me know if you agree with this. TIA
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM